274 related articles for article (PubMed ID: 31730886)
1. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2.
Fonseca BM; Fernandes R; Almada M; Santos M; Carvalho F; Teixeira NA; Correia-da-Silva G
Toxicology; 2019 Feb; 413():40-47. PubMed ID: 30502353
[TBL] [Abstract][Full Text] [Related]
3. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.
Almada M; Costa L; Fonseca BM; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2017 Jun; 385():67-73. PubMed ID: 28495606
[TBL] [Abstract][Full Text] [Related]
4. The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta.
Maia J; Almada M; Midão L; Fonseca BM; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Toxicol Sci; 2020 Oct; 177(2):420-430. PubMed ID: 32647869
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.
Marshell R; Kearney-Ramos T; Brents LK; Hyatt WS; Tai S; Prather PL; Fantegrossi WE
Pharmacol Biochem Behav; 2014 Sep; 124():40-7. PubMed ID: 24857780
[TBL] [Abstract][Full Text] [Related]
6. The psychoactive compound of Cannabis sativa, Δ(9)-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover.
Costa MA; Fonseca BM; Marques F; Teixeira NA; Correia-da-Silva G
Toxicology; 2015 Aug; 334():94-103. PubMed ID: 26070387
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Cannabinoids JWH-122 and THJ-2201 Disrupt Endocannabinoid-Regulated Mitochondrial Function and Activate Apoptotic Pathways as a Primary Mechanism of In Vitro Nephrotoxicity at In Vivo Relevant Concentrations.
Silva JP; Araújo AM; de Pinho PG; Carmo H; Carvalho F
Toxicol Sci; 2019 Jun; 169(2):422-435. PubMed ID: 30796436
[TBL] [Abstract][Full Text] [Related]
10. Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.
Bilel S; Tirri M; Arfè R; Ossato A; Trapella C; Serpelloni G; Neri M; Fattore L; Marti M
Neurotoxicology; 2020 Jan; 76():17-32. PubMed ID: 31610187
[TBL] [Abstract][Full Text] [Related]
11. JWH-018 impairs sensorimotor functions in mice.
Ossato A; Vigolo A; Trapella C; Seri C; Rimondo C; Serpelloni G; Marti M
Neuroscience; 2015 Aug; 300():174-88. PubMed ID: 25987201
[TBL] [Abstract][Full Text] [Related]
12. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.
Wiley JL; Lefever TW; Marusich JA; Grabenauer M; Moore KN; Huffman JW; Thomas BF
Neuropharmacology; 2016 Nov; 110(Pt A):143-153. PubMed ID: 27449567
[TBL] [Abstract][Full Text] [Related]
14. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
Wiley JL; Lefever TW; Cortes RA; Marusich JA
Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
[TBL] [Abstract][Full Text] [Related]
15. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
Wilson CD; Tai S; Ewing L; Crane J; Lockhart T; Fujiwara R; Radominska-Pandya A; Fantegrossi WE
J Pharmacol Exp Ther; 2019 Feb; 368(2):146-156. PubMed ID: 30420360
[TBL] [Abstract][Full Text] [Related]
16. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
Hruba L; Ginsburg BC; McMahon LR
J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.
Su MK; Seely KA; Moran JH; Hoffman RS
Clin Pharmacol Ther; 2015 Jun; 97(6):562-4. PubMed ID: 25788107
[TBL] [Abstract][Full Text] [Related]
18. Influence of structural characteristics on the binding of synthetic cannabinoids from the JWH family to the CB1 receptor: A computational study.
Chaturvedi K; Anthony CS; Pandey P; Doerksen RJ; Godfrey M
J Mol Graph Model; 2024 Jan; 126():108620. PubMed ID: 37722351
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
Tomiyama K; Funada M
Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
[TBL] [Abstract][Full Text] [Related]
20. Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁.
Koller VJ; Zlabinger GJ; Auwärter V; Fuchs S; Knasmueller S
Arch Toxicol; 2013 Jul; 87(7):1287-97. PubMed ID: 23494106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]